NEW YORK, Sept. 02, 2017 -- Pomerantz LLP announces that a class action lawsuit has been filed against Acacia Communications, Inc. (“Acacia” or the “Company”) (NASDAQ:ACIA) and certain of its officers. The class action, filed in United States District Court, District of Massachusetts, and docketed under 17-cv-11504, is on behalf of a class consisting of investors who purchased or otherwise acquired Acacia securities, seeking to recover compensable damages caused by defendants’ violations of the Securities Exchange Act of 1934.
If you are a shareholder who purchased Acacia securities between August 11, 2016, and July 13, 2017, both dates inclusive, you have until October 13, 2017, to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
[Click here to join this class action]
Acacia designs, develops, manufactures, and markets communication equipment. The Company offers high-speed coherent optical interconnect products for cloud infrastructure operators and content and communication service providers. Acacia Communications serves customers worldwide.
The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operational and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) the Company’s manufacturing and quality control processes were deficient; (ii) the foregoing deficiencies were likely to disrupt the Company’s manufacturing, thereby impacting the Company’s revenues; and (iii) as a result of the foregoing, Acacia’s public statements were materially false and misleading at all relevant times.
On May 31, 2017, Acacia issued a press release and filed a Current Report on Form 8-K with the Securities and Exchange Commission, advising investors that “the Company has identified a quality issue” affecting “a portion” of several thousand modules manufactured by one of Acacia’s three contract manufacturers, citing as the “root cause of this quality issue . . . a circuit board cleaning process that has since been eliminated.”
On July 14, 2017, Acacia issued a press release announcing the Company’s preliminary financial and operating results for the quarter ended June 30, 2017. The Company reported profit and revenue that missed estimates, and revised its current-quarter guidance downward. Acacia stated that the Company’s “second-quarter results were adversely affected by the quality issue identified at one of our three contract manufacturers that we announced on May 31.”
On this news, Acacia’s share price fell $2.62, or 6.30%, to close at $39.00 per share on July 14, 2017.
The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.
CONTACT: Robert S. Willoughby Pomerantz LLP [email protected]


AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Italy Fines Apple €98.6 Million Over App Store Dominance
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties 



